Prospective Study to Assess Patient Satisfaction, Quality of Life and Adverse Events of Patients Using the Biojector Versus Standard Needles for Enfuvirtide Administration
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2012
At a glance
- Drugs Enfuvirtide (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 04 Jun 2012 Actual patient number is 337 according to ClinicalTrials.gov.
- 04 Jun 2012 Actual end date (Sept 2008) added as reported by ClinicalTrials.gov.
- 04 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.